|

68Ga-pentixafor Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since July 2026

Pipeline

Early 1: 2

Top Sponsors

  • Zhongnan Hospital1
  • Memorial Sloan Kettering Cancer Center1
  • First Affiliated Hospital of Fujian Medical University1

Indications

  • Cancer3
  • Multiple Myeloma2
  • CXCR41
  • Rosai-Dorfman Disease1
  • Erdheim-Chester Disease1

Other2 trials

CXCR4-targeted PET/CT Imaging in Hematological Malignancies
N/A
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
Early 1

New York, New York1 trial

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Memorial Sloan Kettering Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.